A novel process for preparing thiazolidinediones preferably Pioglitazone as described. Also described are novel intermediates involved in its synthesis and process for their preparation and use in medicine.

The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and pioglitazone processes for the preparation thereof and their use to treat certain diseases.

The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and pioglitazone, processes for the preparation thereof, and their use to treat certain diseases.

There is provided a pharmaceutical composition that is adapted for pulmonary administration by inhalation which composition comprises a glitazone such as pioglitazone or rosiglitazone and one or more pharmaceutically acceptable carriers and/or excipients and wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer. There is also provided a use and a kit.

A new treatment for individuals suffering from type 2 diabetes. The formulation used in the treatment includes a mixture of a thiazoleineione an insulin cinnamon bark extract and at least one synergistic supplement selected from the group consisting of blueberry leaf extract cranberry extract kelp extract sugar sea beet extract acerola berry extract; ginger root extract black cherry extract green tea extract Irish moss extract aloe vera extract and Stevia leaf extract. The thiazoleineione is pre...

A solid preparation containing compound (I) wherein the definition of compound (I) is as defined in the description and pioglitazone which is useful as a therapeutic drug for diabetes and the like and superior in the dissolution property chemical stability and dissolution stability is provided. A solid preparation containing the following first and second parts: (1) the first part containing compound (I) or a salt thereof and as the first excipient sugar or sugar alcohol; and (2) the second part...

A solid preparation sufficiently masking the unpleasant taste of pioglitazone or a salt thereof; a solid preparation sufficiently masking the unpleasant taste of pioglitazone or a salt thereof and having superior properties of superior disintegration property in the oral cavity appropriate preparation strength long-term preservation stability and the like is provided. The present invention provides a solid preparation comprising particles comprising (i) core particles comprising an excipient and...